As the MvPI is an important programme for reporting adverse events, coordinated analysis, etc related to medical devices, including in-vitro diagnostic devices, it is suggested that all licence holders should also use the MvPI platform for reporting any adverse events/serious adverse events associated with the devices to enhance the procedure for identifying risks associated with medical devices.